At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
ACP +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA)
In Brief
A clinical study evaluating ACP and Placebo for Osteoarthritis. Completed, enrolled 90 participants across 4 sites.
Detailed Summary
This study is primarily investigating the effectiveness of Autologous Conditioned Plasma (ACP) Intra-articular (IA) in patients with Osteoarthritis (OA) in the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2016
Enrollment StartJul 2016
Primary CompletionJul 2018
Study CompletionAug 2018
TodayJul 2026
First PostedMar 18, 2016
Enrollment StartJul 1, 2016
Primary CompletionJul 2, 2018
Study CompletionAug 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 10.3 years ago
Interventions
ACPdevice
Autologous Conditioned Plasma
Placeboother
Three Normal Saline IA injections of 3-8 mL at 1-week intervals.